Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 13/20 | 0.47 |
| ▸ | CTSL | P07711 | 8/20 | 0.37 |
| ▸ | CTSS | P25774 | 7/20 | 0.37 |
| ▸ | CTSB | P07858 | 3/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | CTSV | O60911 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4044504 | 0.99 | CTSK (0.48) | CTSKCTSLCTSSCTSBDPP8 | |
| SCHEMBL4042551 | 0.91 | CTSK (0.47) | CTSKCTSLCTSSCTSBMEN1 | |
| SCHEMBL4042518 | 0.90 | CTSK (0.50) | CTSKCTSLCTSSCTSBMEN1 | |
| SCHEMBL4043104 | 0.90 | CTSK (0.47) | CTSKCTSLCTSSCTSBMEN1 | |
| SCHEMBL4053213 | 0.89 | CTSK (0.49) | CTSKCTSLCTSSCTSBDPP4 | |
| SCHEMBL4044989 | 0.89 | CTSK (0.53) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL4041942 | 0.89 | CTSK (0.49) | CTSKCTSLCTSSCTSBMEN1 | |
| SCHEMBL4051385 | 0.89 | CTSK (0.49) | CTSKCTSLCTSSCTSBMEN1 | |
| SCHEMBL4049584 | 0.89 | CTSK (0.51) | CTSKCTSLCTSSCTSB | |
| SCHEMBL4048116 | 0.88 | CTSK (0.48) | CTSKCTSLCTSSCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1689720-B1 | PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS | AVENTIS PHARMA SA (FR) | 2009-04-15 | — | — | EP | claimed |